Utah Medical Products (NASDAQ:UTMD) Share Price Passes Above 50-Day Moving Average – Time to Sell?

Utah Medical Products, Inc. (NASDAQ:UTMD)’s share price crossed above its 50-day moving average during trading on Tuesday . The stock has a 50-day moving average of $66.86 and traded as high as $71.53. Utah Medical Products shares last traded at $69.33, with a volume of 10,441 shares trading hands.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings restated a “hold (c-)” rating on shares of Utah Medical Products in a report on Friday, May 22nd. One investment analyst has rated the stock with a Hold rating, According to data from MarketBeat, Utah Medical Products currently has an average rating of “Hold”.

Utah Medical Products Stock Up 0.5%

The company has a market capitalization of $217.45 million, a PE ratio of 20.23 and a beta of 0.36. The company has a 50-day moving average price of $66.92 and a two-hundred day moving average price of $64.48.

Utah Medical Products (NASDAQ:UTMD) last announced its quarterly earnings results on Thursday, April 23rd. The medical instruments supplier reported $0.82 earnings per share (EPS) for the quarter. Utah Medical Products had a net margin of 28.90% and a return on equity of 9.13%. The firm had revenue of $8.72 million for the quarter.

Utah Medical Products Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, July 3rd. Shareholders of record on Wednesday, June 17th were paid a dividend of $0.31 per share. The ex-dividend date of this dividend was Wednesday, June 17th. This represents a $1.24 annualized dividend and a yield of 1.8%. Utah Medical Products’s payout ratio is 36.69%.

Hedge Funds Weigh In On Utah Medical Products

A number of large investors have recently bought and sold shares of UTMD. Invesco Ltd. boosted its position in Utah Medical Products by 4.2% during the 4th quarter. Invesco Ltd. now owns 6,020 shares of the medical instruments supplier’s stock valued at $337,000 after acquiring an additional 243 shares in the last quarter. O Shaughnessy Asset Management LLC raised its position in shares of Utah Medical Products by 2.3% in the 4th quarter. O Shaughnessy Asset Management LLC now owns 14,903 shares of the medical instruments supplier’s stock worth $834,000 after acquiring an additional 337 shares in the last quarter. &PARTNERS lifted its stake in shares of Utah Medical Products by 11.6% in the 4th quarter. &PARTNERS now owns 3,796 shares of the medical instruments supplier’s stock valued at $212,000 after purchasing an additional 396 shares during the period. Sei Investments Co. lifted its stake in shares of Utah Medical Products by 11.4% in the 1st quarter. Sei Investments Co. now owns 4,097 shares of the medical instruments supplier’s stock valued at $254,000 after purchasing an additional 419 shares during the period. Finally, Comerica Bank boosted its position in shares of Utah Medical Products by 435.6% during the third quarter. Comerica Bank now owns 541 shares of the medical instruments supplier’s stock valued at $34,000 after purchasing an additional 440 shares in the last quarter. 69.60% of the stock is owned by hedge funds and other institutional investors.

About Utah Medical Products

Utah Medical Products, Inc (NASDAQ: UTMD), headquartered in Midvale, Utah, is a designer, manufacturer and marketer of single‐use medical devices focusing principally on respiratory therapy and patient monitoring applications. Since its founding in the late 1970s, the company has built a reputation for innovation in airway management and non‐invasive monitoring products used in acute and long‐term care settings.

The company’s core product portfolio includes tracheostomy tubes and related accessories, endotracheal tube holders, disposable catheters and sensors for measuring end‐tidal carbon dioxide (CO₂).